Published in Pharmacol Ther on February 19, 2010
Metabotropic glutamate receptors as therapeutic targets for schizophrenia. Neuropharmacology (2011) 1.10
Modeling treatment-resistant depression. Neuropharmacology (2011) 0.93
α2-Adrenoceptors are targets for antipsychotic drugs. Psychopharmacology (Berl) (2014) 0.88
Serotonin receptor expression in human prefrontal cortex: balancing excitation and inhibition across postnatal development. PLoS One (2011) 0.86
Aripiprazole: from pharmacological profile to clinical use. Neuropsychiatr Dis Treat (2015) 0.84
Synthesis and evaluation of a series of 2-substituted-5-thiopropylpiperazine (piperidine)-1,3,4-oxadiazoles derivatives as atypical antipsychotics. PLoS One (2012) 0.80
Modulation of neuronal plasticity following chronic concomitant administration of the novel antipsychotic lurasidone with the mood stabilizer valproic acid. Psychopharmacology (Berl) (2012) 0.79
Convergence of melatonin and serotonin (5-HT) signaling at MT2/5-HT2C receptor heteromers. J Biol Chem (2015) 0.78
TLX-Its Emerging Role for Neurogenesis in Health and Disease. Mol Neurobiol (2016) 0.75
Etiology and antibiotic resistance patterns of community-acquired urinary tract infections in J N M C Hospital Aligarh, India. Ann Clin Microbiol Antimicrob (2007) 3.07
3,4-dihydroxyphenylalanine reverses the motor deficits in Pitx3-deficient aphakia mice: behavioral characterization of a novel genetic model of Parkinson's disease. J Neurosci (2005) 1.52
Effects of newer antipsychotics on extrapyramidal function. CNS Drugs (2002) 1.50
Animal models of attention-deficit hyperactivity disorder. Brain Res Brain Res Rev (2003) 1.36
Bapineuzumab and solanezumab for Alzheimer's disease: is the 'amyloid cascade hypothesis' still alive? Expert Opin Biol Ther (2013) 1.12
Asenapine, a novel psychopharmacologic agent: preclinical evidence for clinical effects in schizophrenia. Psychopharmacology (Berl) (2007) 1.11
Pharmacotherapies for Alzheimer's disease: beyond cholinesterase inhibitors. Pharmacol Ther (2011) 1.03
Long-term effects of prenatal stress on dopamine and glutamate receptors in adult rat brain. Neurochem Res (2002) 1.00
Effects of norepinephrine and serotonin transporter inhibitors on hyperactivity induced by neonatal 6-hydroxydopamine lesioning in rats. J Pharmacol Exp Ther (2002) 0.97
Asenapine restores cognitive flexibility in rats with medial prefrontal cortex lesions. Psychopharmacology (Berl) (2008) 0.95
Repeated antipsychotic drug exposure in developing rats: dopamine receptor effects. Synapse (2006) 0.95
Regulation of working memory by dopamine D4 receptor in rats. Neuropsychopharmacology (2004) 0.93
Enhanced expression of dopamine D(1) and glutamate NMDA receptors in dopamine D(4) receptor knockout mice. J Mol Neurosci (2004) 0.92
Effects of repeated risperidone exposure on serotonin receptor subtypes in developing rats. Eur Neuropsychopharmacol (2009) 0.91
Metabotropic and ionotropic glutamate receptors as neurobiological targets in anxiety and stress-related disorders: focus on pharmacology and preclinical translational models. Pharmacol Biochem Behav (2011) 0.91
Effects of risperidone on dopamine receptor subtypes in developing rat brain. Eur Neuropsychopharmacol (2006) 0.90
Effects of risperidone on glutamate receptor subtypes in developing rat brain. Eur Neuropsychopharmacol (2008) 0.90
Stereoselective effects of methylphenidate on motor hyperactivity in juvenile rats induced by neonatal 6-hydroxydopamine lesioning. Psychopharmacology (Berl) (2001) 0.90
Acute oral dexamethasone administration reduces levels of orphan GPCR glucocorticoid-induced receptor (GIR) mRNA in rodent brain: potential role in HPA-axis function. Brain Res Mol Brain Res (2003) 0.89
Asenapine increases dopamine, norepinephrine, and acetylcholine efflux in the rat medial prefrontal cortex and hippocampus. Neuropsychopharmacology (2008) 0.87
Early adoption modifies the effects of prenatal stress on dopamine and glutamate receptors in adult rat brain. J Neurosci Res (2004) 0.86
Electrophysiological characterization of the effects of asenapine at 5-HT(1A), 5-HT(2A), alpha(2)-adrenergic and D(2) receptors in the rat brain. Eur Neuropsychopharmacol (2008) 0.85
Asenapine effects in animal models of psychosis and cognitive function. Psychopharmacology (Berl) (2009) 0.85
Atomoxetine blocks motor hyperactivity in neonatal 6-hydroxydopamine-lesioned rats: implications for treatment of attention-deficit hyperactivity disorder. Int J Neuropsychopharmacol (2005) 0.85
Differential regional and dose-related effects of asenapine on dopamine receptor subtypes. Psychopharmacology (Berl) (2008) 0.84
Asenapine improves phencyclidine-induced object recognition deficits in the rat: evidence for engagement of a dopamine D1 receptor mechanism. Psychopharmacology (Berl) (2010) 0.84
Synthesis and dopamine receptor affinities of N-alkyl-11-hydroxy-2-methoxynoraporphines: N-alkyl substituents determine D1 versus D2 receptor selectivity. J Med Chem (2008) 0.83
Multi- and single-target agents for major psychiatric diseases: therapeutic opportunities and challenges. Curr Opin Investig Drugs (2008) 0.83
Serotonin transporter binding increases in caudate-putamen and nucleus accumbens after neonatal 6-hydroxydopamine lesions in rats: implications for motor hyperactivity. Brain Res Dev Brain Res (2002) 0.83
Effects of asenapine on prefrontal N-methyl-D-aspartate receptor-mediated transmission: involvement of dopamine D1 receptors. Synapse (2010) 0.82
Phencyclidine (PCP)-induced disruption in cognitive performance is gender-specific and associated with a reduction in brain-derived neurotrophic factor (BDNF) in specific regions of the female rat brain. J Mol Neurosci (2010) 0.82
Asenapine effects on cognitive and monoamine dysfunction elicited by subchronic phencyclidine administration. Neuropharmacology (2011) 0.82
The ampakine, Org 26576, bolsters early spatial reference learning and retrieval in the Morris water maze: a subchronic, dose-ranging study in rats. Behav Pharmacol (2009) 0.82
Development of SPECT imaging agents for the norepinephrine transporters: [123I]INER. Bioorg Med Chem Lett (2006) 0.81
Chronic treatment with AMPA receptor potentiator Org 26576 increases neuronal cell proliferation and survival in adult rodent hippocampus. Psychopharmacology (Berl) (2009) 0.80
Validation of a rat in vivo [(3)H]M100907 binding assay to determine a translatable measure of 5-HT(2A) receptor occupancy. Eur J Pharmacol (2008) 0.80
Synthesis and binding studies of 2-O- and 11-O-substituted N-alkylnoraporphines. Bioorg Med Chem Lett (2008) 0.80
Translational PK-PD modelling of molecular target modulation for the AMPA receptor positive allosteric modulator Org 26576. Psychopharmacology (Berl) (2011) 0.80
R-(-)-N-alkyl-11-hydroxy-10-hydroxymethyl- and 10-methyl-aporphines as 5-HT1A receptor ligands. Bioorg Med Chem Lett (2007) 0.80
Attenuation of chronic mild stress-induced 'anhedonia' by asenapine is not associated with a 'hedonic' profile in intracranial self-stimulation. J Psychopharmacol (2010) 0.80
Effects of asenapine, olanzapine, and risperidone on psychotomimetic-induced reversal-learning deficits in the rat. Behav Brain Res (2010) 0.80
Repeated effects of asenapine on adrenergic and cholinergic muscarinic receptors. Int J Neuropsychopharmacol (2009) 0.80
Asenapine elevates cortical dopamine, noradrenaline and serotonin release. Evidence for activation of cortical and subcortical dopamine systems by different mechanisms. Psychopharmacology (Berl) (2009) 0.80
Subchronic effects of phencyclidine on dopamine and serotonin receptors: implications for schizophrenia. J Mol Neurosci (2009) 0.79
SleepAp: an automated obstructive sleep apnoea screening application for smartphones. IEEE J Biomed Health Inform (2015) 0.79
Plasticity of dopamine D4 receptors in rat forebrain: temporal association with motor hyperactivity following neonatal 6-hydroxydopamine lesioning. Neuropsychopharmacology (2002) 0.79
Regionally selective and dose-dependent effects of the ampakines Org 26576 and Org 24448 on local cerebral glucose utilisation in the mouse as assessed by 14C-2-deoxyglucose autoradiography. Neuropharmacology (2005) 0.79
Effects of dopamine D4 receptor-selective antagonists on motor hyperactivity in rats with neonatal 6-hydroxydopamine lesions. Psychopharmacology (Berl) (2002) 0.79
Alterations in dopamine and glutamate neurotransmission in tetrahydrobiopterin deficient spr-/- mice: relevance to schizophrenia. BMB Rep (2010) 0.78
Asenapine exerts distinctive regional effects on ionotropic glutamate receptor subtypes in rat brain. Synapse (2009) 0.78
Asenapine maleate: a new drug for the treatment of schizophrenia and bipolar mania. Drugs Today (Barc) (2009) 0.77
New pyridobenzoxazepine derivatives derived from 5-(4-methylpiperazin-1-yl)-8-chloro-pyrido[2,3-b][1,5]benzoxazepine (JL13): chemical synthesis and pharmacological evaluation. J Med Chem (2012) 0.77
Effects of antidepressant drug exposure on gene expression in the developing cerebral cortex. Synapse (2014) 0.77
A translational approach to evaluate the efficacy and safety of the novel AMPA receptor positive allosteric modulator org 26576 in adult attention-deficit/hyperactivity disorder. Biol Psychiatry (2012) 0.77
Effects of prenatal stress on dopamine D2 receptor asymmetry in rat brain. Synapse (2007) 0.77
Differential effects of AMPA receptor potentiators and glycine reuptake inhibitors on antipsychotic efficacy and prefrontal glutamatergic transmission. Psychopharmacology (Berl) (2011) 0.76
Organotypic rat cerebellar slice culture as a model to analyze the molecular pharmacology of GABAA receptors. Eur Neuropsychopharmacol (2002) 0.76
Pharmacological characterization of the norepinephrine and dopamine reuptake inhibitor EB-1020: implications for treatment of attention-deficit hyperactivity disorder. Synapse (2012) 0.76
The AMPA receptor potentiator Org 26576 modulates stress-induced transcription of BDNF isoforms in rat hippocampus. Pharmacol Res (2011) 0.76
The α2C-adrenoceptor antagonist, ORM-10921, exerts antidepressant-like effects in the Flinders Sensitive Line rat. Behav Pharmacol (2016) 0.75
Compatibility of electroanatomical mapping systems with a concurrent percutaneous axial flow ventricular assist device. J Cardiovasc Electrophysiol (2014) 0.75
Synthesis and neuropharmacological evaluation of esters of R(-)-N-alkyl-11-hydroxy-2-methoxynoraporphines. Bioorg Med Chem Lett (2008) 0.75
Long-term effects of JL 13, a potential atypical antipsychotic, on rat dopamine and serotonin receptor subtypes. J Neurosci Res (2006) 0.75